{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:01:24Z","timestamp":1791615684817,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,9]],"date-time":"2017-04-09T00:00:00Z","timestamp":1491696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ymthe.2017.03.035","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T18:45:51Z","timestamp":1493318751000},"page":"1316-1327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":622,"title":["Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses"],"prefix":"10.1016","volume":"25","author":[{"given":"Kapil","family":"Bahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe J.","family":"Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Yuzhakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bulychev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly J.","family":"Hassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Laska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6rn","family":"Almarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilcar (Mick)","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Zaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ciaramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.03.035_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7774\/cevr.2014.3.2.140","article-title":"Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of \u201cmix and match\u201d","volume":"3","author":"Pascua","year":"2014","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.ymthe.2017.03.035_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra1208802","article-title":"Pandemic preparedness and response--lessons from the H1N1 influenza of 2009","volume":"370","author":"Fineberg","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.035_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2017.03.035_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"issue":"Suppl 4","key":"10.1016\/j.ymthe.2017.03.035_bib5","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2017.03.035_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/cit479","article-title":"Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan","volume":"57","author":"Yuan","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2017.03.035_bib7","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.035_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(14)60111-2","article-title":"Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study","volume":"383","author":"Chen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2017.03.035_bib9","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.celrep.2015.08.029","article-title":"Testing the effect of internal genes derived from a wild-bird-origin H9N2 influenza A virus on the pathogenicity of an A\/H7N9 Virus","volume":"12","author":"Su","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2017.03.035_bib10","unstructured":"World Health Organization (2017). Influenza at the human-animal interface. http:\/\/www.who.int\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_01_16_2017_FINAL.pdf?ua=1."},{"key":"10.1016\/j.ymthe.2017.03.035_bib11","first-page":"3238","article-title":"Clinical characteristics of human infection with a novel avian-origin influenza A(H10N8) virus","volume":"127","author":"Zhang","year":"2014","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ymthe.2017.03.035_bib12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl 4","key":"10.1016\/j.ymthe.2017.03.035_bib13","doi-asserted-by":"crossref","first-page":"D41","DOI":"10.1016\/j.vaccine.2008.07.043","article-title":"Correlates of protection: novel generations of influenza vaccines","volume":"26","author":"Rimmelzwaan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2017.03.035_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coi.2013.07.005","article-title":"Correlates of protection against influenza infection in humans--on the path to a universal vaccine?","volume":"25","author":"Li","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12703\/P6-47","article-title":"Advances in influenza vaccination","volume":"6","author":"Reperant","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.ymthe.2017.03.035_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next\u00a0generation influenza vaccines: Formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ymthe.2017.03.035_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2017.03.035_bib18","unstructured":"World Health Organization (2009). Pandemic influenza vaccine manufacturing process and timeline. http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_vaccine_20090806\/en\/."},{"key":"10.1016\/j.ymthe.2017.03.035_bib19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMcp1512870","article-title":"CLINICAL PRACTICE. Influenza Vaccination","volume":"375","author":"Treanor","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.035_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in\u00a0vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib21","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4161\/hv.25181","article-title":"A novel, disruptive vaccination technology: self-adjuvanted RNActive(\u00ae) vaccines","volume":"9","author":"Kallen","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2017.03.035_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.035_bib23","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Karik\u00f3","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.03.035_bib24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri3247","article-title":"Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination","volume":"12","author":"Desmet","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.03.035_bib26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/emboj.2013.80","article-title":"Mapping the crossroads of immune activation and cellular stress response pathways","volume":"32","author":"Cl\u00e1udio","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2017.03.035_bib27","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1093\/nar\/gkr586","article-title":"Nucleoside modifications in RNA limit activation of 2\u2032-5\u2032-oligoadenylate synthetase and increase resistance to cleavage by RNase L","volume":"39","author":"Anderson","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.03.035_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/nar\/27.1.196","article-title":"The RNA modification database: 1999 update","volume":"27","author":"Rozenski","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.03.035_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.03.035_bib30","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA Vaccines Protect against Zika Virus Infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2017.03.035_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.03.035_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ymthe.2017.03.035_bib33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/gt.2015.35","article-title":"Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine","volume":"22","author":"Riede","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.035_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/15376510802312464","volume":"5","author":"Sheets","year":"2008","journal-title":"J.\u00a0Immunotoxicol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib35","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/nar\/gks1282","article-title":"A novel mechanism of eukaryotic translation initiation that is neither m7G-cap-, nor IRES-dependent","volume":"41","author":"Terenin","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.03.035_bib36","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/v20801530","article-title":"Animal models for influenza virus pathogenesis and transmission","volume":"2","author":"Bouvier","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2017.03.035_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1242\/dmm.007823","article-title":"The ferret as a model organism to study influenza A virus infection","volume":"4","author":"Belser","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2017.03.035_bib38","unstructured":"US Department of Health and Human Services (2007). Guidance for industry toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. https:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Vaccines\/ucm074775.htm."},{"key":"10.1016\/j.ymthe.2017.03.035_bib39","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa0907413","article-title":"Response to a monovalent 2009 influenza A (H1N1) vaccine","volume":"361","author":"Greenberg","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.035_bib40","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00207-09","article-title":"Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra","volume":"16","author":"Reisinger","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/655830","article-title":"AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age","volume":"51","author":"Roman","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2017.03.035_bib42","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in\u00a0vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.03.035_bib43","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/CJI.0b013e3181a00068","article-title":"Direct injection of protamine-protected mRNA: results of a phase 1\/2 vaccination trial in metastatic melanoma patients","volume":"32","author":"Weide","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2017.03.035_bib44","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2010.04.083","article-title":"Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets","volume":"28","author":"Partridge","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2017.03.035_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/JVI.01786-15","article-title":"Induction of broad-based immunity and protective efficacy by self-amplifying mRNA vaccines encoding influenza virus hemagglutinin","volume":"90","author":"Brazzoli","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib46","doi-asserted-by":"crossref","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.035_bib47","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1038\/emi.2013.54","article-title":"Rapidly produced SAM(\u00ae) vaccine against H7N9 influenza is immunogenic in mice","volume":"2","author":"Hekele","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ymthe.2017.03.035_bib48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0882-4010(95)90290-2","article-title":"Viremia induced by influenza virus","volume":"19","author":"Mori","year":"1995","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ymthe.2017.03.035_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ymthe.2017.03.035_bib50","doi-asserted-by":"crossref","first-page":"234ra55","DOI":"10.1126\/scitranslmed.3008761","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.03.035_bib51","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ymthe.2017.03.035_bib52","article-title":"Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB\/c mice","author":"Lu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib53","doi-asserted-by":"crossref","first-page":"e1002381","DOI":"10.1371\/journal.ppat.1002381","article-title":"Cross-reactive T\u00a0cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates","volume":"7","author":"Weinfurter","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2017.03.035_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"Li","year":"2012","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.ymthe.2017.03.035_bib55","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2017.03.035_bib56","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1093\/nar\/26.13.3208","article-title":"Cap ribose methylation of c-mos mRNA stimulates translation and oocyte maturation in Xenopus laevis","volume":"26","author":"Kuge","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.03.035_bib57","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/nar\/25.15.2979","article-title":"A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules\/ml","volume":"25","author":"Collins","year":"1997","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.1016\/j.ymthe.2022.07.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000}}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617301569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617301569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T11:44:41Z","timestamp":1601984681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617301569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1525001617301569"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors.","name":"copyright","label":"Copyright"}]}}